Transdermal Drug Delivery For CNS Conditions Expected To Exceed $1 Billion By 2012

While often overshadowed in the public consciousness by cancer and heart disease, recent trends in certain pathologies of the central nervous system are becoming equally challenging for clinicians and researchers. Growth in the incidence of a number of neurological conditions such as Alzheimer’s and Parkinson’s has captured the concerns of healthcare professionals, and reached the public at large through personal experience and the media.

More: continued here

Filed under: Neurology / Neuroscience on June 1st, 2009